Protalix BioTherapeutics (PLX)
(Delayed Data from AMEX)
$1.12 USD
+0.02 (1.82%)
Updated Sep 23, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | 0.06 |
EPS Last Quarter | -0.03 |
Last EPS Surprise | -250.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.06 |
Next Year | 0.62 |
EPS (TTM) | -0.20 |
P/E (F1) | 18.67 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 16.26M | 20.21M | 53.69M | 101.44M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 16.26M | 20.21M | 53.69M | 101.44M |
Low Estimate | 16.26M | 20.21M | 53.69M | 101.44M |
Year ago Sales | 10.35M | 10.49M | 65.49M | 53.69M |
Year over Year Growth Est. | 57.10% | 92.66% | -18.02% | 88.94% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.06 | 0.10 | 0.06 | 0.62 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | 0.06 | 0.10 | 0.06 | 0.62 |
High Estimate | 0.06 | 0.10 | 0.06 | 0.62 |
Low Estimate | 0.06 | 0.10 | 0.06 | 0.62 |
Year ago EPS | -0.04 | -0.07 | 0.09 | 0.06 |
Year over Year Growth Est. | 250.00% | 242.86% | -33.33% | 933.33% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.06 | 0.10 | 0.06 | 0.62 |
7 Days Ago | 0.06 | 0.10 | 0.06 | 0.62 |
30 Days Ago | 0.06 | 0.10 | 0.06 | 0.62 |
60 Days Ago | 0.06 | 0.10 | 0.12 | 0.63 |
90 Days Ago | 0.06 | 0.10 | 0.12 | 0.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.06 | 0.10 | 0.06 | 0.62 |
Zacks Consensus Estimate | 0.06 | 0.10 | 0.06 | 0.62 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.03 | -0.06 | -0.07 | -0.04 | NA |
Estimate | 0.02 | NA | -0.03 | -0.07 | NA |
Difference | -0.05 | NA | -0.04 | 0.03 | -0.02 |
Surprise | -250.00% | NA | -133.33% | 42.86% | -113.49% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more